CLDN2 and non-small cell lung carcinoma: CLDN2, significantly upregulated in NSCLC tissues versus paired normal tissues, promoted tumor cell proliferation and cisplatin resistance by upregulating multidrug resistance-associated protein 2 (MRP2).